Guse Kyle

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(1%)82%(6%)(68%)0%
Purchase Success Rate0 of 11 of 10 of 10 of 10 of 1
Average Sale Return----------
Sale Success Rate----------

Atossa Therapeutics, Inc.

Drugs » Diagnostic Substances

CFO, Gen Counsel and Secretary:

Holdings: 10.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--